Log In
Print
BCIQ
Print
Print this Print this
 

bardoxolone methyl (formerly RTA 402)

Also known as: CDDO-Me

  Manage Alerts
Collapse Summary General Information
Company Reata Pharmaceuticals Inc.
DescriptionSmall molecule activator of nuclear factor (erythroid-derived 2)-like 2 (NFE2L2; NRF2)
Molecular Target Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) (NRF2) ; Signal transducer and activator of transcription 3 (STAT3)
Mechanism of ActionNF-kappa B (NF-kB) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today